Co-proxamol

Co-proxamol (BAN, also coproxamol) is a combination of the analgesics dextropropoxyphene (an opioid) and paracetamol.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) decided in 2005 to withdraw co-proxamol from the market following advice from the Committee on Safety of Medicines (CSM) that co-proxamol is little more effective than paracetamol alone as an analgesic, but that it was associated with higher fatality rates if a drug overdose were intentionally or inadvertently taken. The decision provoked some outcry from long-term users of the drug.